Cargando…

Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program

AIM: Survival of patients with Hodgkin’s lymphoma is lower in in low- and middle-income countries, but factors leading to these outcomes are poorly understood. The objective of this study was to identify predictive factors associated with overall survival among cancer patients undergoing therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladner, Joël, Madi, Farah, Jayasundera, Roshel, Saba, Joseph, Audureau, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508316/
https://www.ncbi.nlm.nih.gov/pubmed/37278943
http://dx.doi.org/10.57264/cer-2022-0210
_version_ 1785107510770794496
author Ladner, Joël
Madi, Farah
Jayasundera, Roshel
Saba, Joseph
Audureau, Etienne
author_facet Ladner, Joël
Madi, Farah
Jayasundera, Roshel
Saba, Joseph
Audureau, Etienne
author_sort Ladner, Joël
collection PubMed
description AIM: Survival of patients with Hodgkin’s lymphoma is lower in in low- and middle-income countries, but factors leading to these outcomes are poorly understood. The objective of this study was to identify predictive factors associated with overall survival among cancer patients undergoing therapy in seven low- and middle-income countries. MATERIALS & METHODS: A multicenter cohort was conducted in Egypt, Malaysia, Mexico, Peru, Philippines, Thailand and Ukraine. Results. A total of 460 patients were included. Phone-based support during patient follow-up and number of patients seen by the physician provided a positive impact, while the number of adverse events remains a predictor of death and physician decision to stop treatment. CONCLUSION: Furthers research on the potential benefit of phone-based programs to support patients with chronic diseases treatments should be explored in less developed countries.
format Online
Article
Text
id pubmed-10508316
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Becaris Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-105083162023-09-20 Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program Ladner, Joël Madi, Farah Jayasundera, Roshel Saba, Joseph Audureau, Etienne J Comp Eff Res Research Article AIM: Survival of patients with Hodgkin’s lymphoma is lower in in low- and middle-income countries, but factors leading to these outcomes are poorly understood. The objective of this study was to identify predictive factors associated with overall survival among cancer patients undergoing therapy in seven low- and middle-income countries. MATERIALS & METHODS: A multicenter cohort was conducted in Egypt, Malaysia, Mexico, Peru, Philippines, Thailand and Ukraine. Results. A total of 460 patients were included. Phone-based support during patient follow-up and number of patients seen by the physician provided a positive impact, while the number of adverse events remains a predictor of death and physician decision to stop treatment. CONCLUSION: Furthers research on the potential benefit of phone-based programs to support patients with chronic diseases treatments should be explored in less developed countries. Becaris Publishing Ltd 2023-06-06 /pmc/articles/PMC10508316/ /pubmed/37278943 http://dx.doi.org/10.57264/cer-2022-0210 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Article
Ladner, Joël
Madi, Farah
Jayasundera, Roshel
Saba, Joseph
Audureau, Etienne
Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title_full Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title_fullStr Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title_full_unstemmed Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title_short Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
title_sort phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508316/
https://www.ncbi.nlm.nih.gov/pubmed/37278943
http://dx.doi.org/10.57264/cer-2022-0210
work_keys_str_mv AT ladnerjoel phonecontactsandtreatmentdiscontinuationpredictsurvivalcancerpatientsinasubsidizeddrugaccessprogram
AT madifarah phonecontactsandtreatmentdiscontinuationpredictsurvivalcancerpatientsinasubsidizeddrugaccessprogram
AT jayasunderaroshel phonecontactsandtreatmentdiscontinuationpredictsurvivalcancerpatientsinasubsidizeddrugaccessprogram
AT sabajoseph phonecontactsandtreatmentdiscontinuationpredictsurvivalcancerpatientsinasubsidizeddrugaccessprogram
AT audureauetienne phonecontactsandtreatmentdiscontinuationpredictsurvivalcancerpatientsinasubsidizeddrugaccessprogram